JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).
dc.contributor.author | Sharma, Maitreyi | |
dc.contributor.author | Muntean, Alina | |
dc.contributor.author | le Sourd, Samuel | |
dc.contributor.author | Vaccaro, Gina M. | |
dc.contributor.author | Taieb, Julien | |
dc.contributor.author | Boku, Narikazu | |
dc.contributor.author | Xiong, Huiling | |
dc.contributor.author | Conti, Ilaria | |
dc.contributor.author | Bang, Yung-Jue | |
dc.contributor.author | Ozguroglu, Mustafa | |
dc.contributor.author | Moehler, Markus H. | |
dc.contributor.author | Ryu, Min-Hee | |
dc.contributor.author | Lee, Keun-Wook | |
dc.contributor.author | Coskun, Hasan Senol | |
dc.contributor.author | Wong, Rachel | |
dc.contributor.author | Chung, Hyun-Choel | |
dc.contributor.author | Poltoratsky, Artem | |
dc.contributor.author | Tsuji, Akihito | |
dc.contributor.author | Yen, Chia-Jui | |
dc.date.accessioned | 2021-03-03T08:12:13Z | |
dc.date.available | 2021-03-03T08:12:13Z | |
dc.identifier.citation | Moehler M. H. , Ryu M., Lee K., Coskun H. S. , Wong R., Ozguroglu M., Chung H., Poltoratsky A., Tsuji A., Yen C., et al., "JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC).", Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 18 - 20 Ocak 2018, cilt.36 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_1649e64d-4c10-4bc1-8290-29b6cc90d197 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/20330 | |
dc.identifier.uri | https://doi.org/10.1200/jco.2018.36.4_suppl.tps195 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.title | JAVELIN Gastric 100: Phase 3 trial of avelumab (anti-PD-L1) maintenance therapy versus continuation of first-line chemotherapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC). | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 36 | |
dc.contributor.firstauthorID | 153016 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]